Metabolic Solutions

Main menu

Skip to primary content
Skip to secondary content
  • Home
  • About
    • Management
    • Board of Managers
    • Scientific and Medical Advisory Board
    • Academic Collaborators
    • CRO Network
  • Science
    • Target
    • Metabolic Syndrome
    • Type 2 Diabetes
    • Insulin Sensitizers
    • Polycystic Kidney Disease
    • Neurodegeneration Diseases
    • Fatty Liver Disease
  • Pipeline
    • MSDC-0160
    • MSDC-0602
  • Newsroom
    • News Releases
    • In the News
    • Publications
    • Presentations
    • Fact Sheet
  • Contact
    • Location
    • Careers
    • Media Contact
  • Insights
Next »

Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.

News

5.21.2013

Metabolic Solutions finds diabetes ‘breakthrough’ at life sciences incubator

Insights

Pipeline
Beaker
  • Twitter
  • LinkedIn

© Copyright 2012 Metabolic Solutions
Development Company, LLC
161 E Michigan Ave., 4th Floor
Kalamazoo, MI 49007
269.343.6732

  • Home /
  • About /
    • Management
    • Board of Managers
    • Scientific and Medical Advisory Board
    • Academic Collaborators
    • CRO Network
  • Science /
    • Target
    • Metabolic Syndrome
    • Type 2 Diabetes
    • Insulin Sensitizers
    • Polycystic Kidney Disease
    • Neurodegeneration Diseases
    • Fatty Liver Disease
  • Pipeline /
    • MSDC-0160
    • MSDC-0602
  • Newsroom /
    • News Releases
    • In the News
    • Publications
    • Presentations
    • Fact Sheet
  • Contact /
    • Location
    • Careers
    • Media Contact
  • Insights /